StockData
Bionano Genomics, Inc. logo

Bionano Genomics, Inc. (BNGO) stock

BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3082% below fair value
$0.98+0.02 (+2.50%)

Close on Nov 18, 2026Market cap $11.49MP/E –Yield –

Earnings

Bionano Genomics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 22, 2027
Q4 FY2026 · estimated, during market hours
Revenue, Q3 FY2026
$8.30M
+12.2% on a year earlier
EPS, Q3 FY2026
–
Latest guidance
Raised
Nov 10, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Bionano Genomics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 22, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 10, 2026after the close$8.30M+12.2%–Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026during market hours$8.20M+22.4%–Release
Q1 FY2026ended Mar 31, 2026May 13, 2026during market hours$6.70M+3.1%–Release
Q4 FY2025ended Dec 31, 2025Mar 23, 2026during market hours$8.00M-2.4%–Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025during market hours$7.40M+21.3%–Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025during market hours$6.70M-14.1%–Release
Q1 FY2025ended Mar 31, 2025May 14, 2025during market hours$6.50M-26.1%–Release
Q4 FY2024ended Dec 31, 2024Mar 31, 2025during market hours$8.20M-23.4%–Release
Q3 FY2024ended Sep 30, 2024Nov 13, 2024during market hours$6.10M-34.4%–Release
Q2 FY2024ended Jun 30, 2024Aug 7, 2024during market hours$7.80M-10.3%–Release
Q1 FY2024ended Mar 31, 2024May 8, 2024during market hours$8.80M+18.9%–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Bionano Genomics's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
revenue guidanceFY2026$31.00M – $33.00M$30.00M – $33.00MRaisedNov 10, 2026
revenue guidanceFY2026$31.00M – $33.00M$30.00M – $33.00MRaisedAug 10, 2026

Guidance vs results

The last range Bionano Genomics gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q3 FY2026Revenue$8.20M – $8.60M$8.30MWithin range
Q2 FY2026Revenue$7.50M – $7.80M$8.20MAbove range
Q1 FY2026Revenue$6.50M – $6.70M$6.70MWithin range
FY2025Revenue$26.00M – $30.00M$28.60MΣ4QWithin range
Q4 FY2025Revenue$7.50M – $7.90M$8.00MAbove range
Q3 FY2025Revenue$6.70M – $7.20M$7.40MAbove range
Q2 FY2025Revenue$6.30M – $6.80M$6.70MWithin range
Q1 FY2025Revenue$6.20M – $6.30M$6.50MAbove range
Q3 FY2024Revenue$6.50M – $6.80M$6.10MBelow range
Q2 FY2024Revenue$7.80M – $8.20M$7.80MWithin range
Q1 FY2024Revenue$8.25M – $8.75M$8.80MAbove range
Q4 FY2022Revenue$8.10M – $8.40M$8.20MWithin range

Guidance history

Every forecast Bionano Genomics put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 10, 2026revenue guidanceFY2026$31.00M – $33.00MRaised
Aug 10, 2026revenue guidanceFY2026$31.00M – $33.00MRaised
Aug 10, 2026revenue guidanceQ3 FY2026$8.20M – $8.60MNew
May 13, 2026revenue guidanceFY2026$30.00M – $33.00MNew
May 13, 2026revenue guidanceQ2 FY2026$7.50M – $7.80MNew
Mar 23, 2026revenueQ1 FY2026$6.50M – $6.70MNew
Mar 23, 2026revenueFY2026$30.00M – $33.00MNew
Nov 13, 2025new OGM system installationsFY202525New
Nov 13, 2025revenueFY2025$26.00M – $30.00MNew
Nov 13, 2025revenueQ4 FY2025$7.50M – $7.90MNew
Aug 14, 2025new OGM installation expectationsFY202520 – 25Raised
Aug 14, 2025revenueQ3 FY2025$6.70M – $7.20MNew
Aug 14, 2025revenueFY2025$26.00M – $30.00MReaffirmed
May 14, 2025installation of new OGM systemsFY202515 – 20Reaffirmed
May 14, 2025revenueQ2 FY2025$6.30M – $6.80MNew
May 14, 2025revenueFY2025$26.00M – $30.00MLowered
Mar 31, 2025Installation of new OGM systemsFY202515 – 20New
Mar 31, 2025revenueQ1 FY2025$6.20M – $6.30MNew
Mar 31, 2025revenueFY2025$29.00M – $32.00MNew
Oct 10, 2024revenueQ3 FY2024$6.50M – $6.80MLowered

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Bionano Genomics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. News
  5. News
  6. Results
  7. News
  8. Results
  9. Results
  10. Results
  11. News
  12. News
  13. Results
  14. Results
  15. Results

See a number that looks wrong?